60 DEGREES PHARMACEUTICALS, INC. (SXTPW)

Every figure this model derived for SXTPW, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2026-06-30.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 119,880 PaymentsToAcquirePropertyPlantAndEquipment 2026-06-30
cash 2,263,327 CashAndCashEquivalentsAtCarryingValue 2026-06-30
current assets 3,731,297 AssetsCurrent 2026-06-30
current liabilities 1,605,095 LiabilitiesCurrent 2026-06-30
equity 2,614,185 StockholdersEquity 2026-06-30
interest expense 7,586 InterestExpenseNonoperating 2026-06-30
ocf -8,774,808 NetCashProvidedByUsedInOperatingActivities 2026-06-30
revenue 1,110,977 Revenues 2026-06-30
sbc 413,468 AllocatedShareBasedCompensationExpense 2026-06-30

The ratios

The figures themselves rather than their scores — what somebody looking up SXTPW on one particular measure came for.

RatioValue
cash operating margin-732.19
current ratio2.32
current ratio reported2.32
dilution pct490.35
fcf margin-800.62
growth cv0.71
interest cover-1134.85
operating margin-774.9
owner earnings margin-837.84
revenue growth73.21
revenue growth per share-70.66
roic-1352.39
rule of 40-701.69
sbc pct revenue37.22

What to be careful about

What this model itself distrusts about SXTPW's figures. Written by the derivation as it ran, not added afterwards.